Selective aurora kinase inhibitors identified using a taxol-induced checkpoint sensitivity screen

Nicholas Kwiatkowski, Xianming Deng, Jinhua Wang, Li Tan, Fabrizio Villa, Stefano Santaguida, Hsiao Chun Huang, Tim Mitchison, Andrea Musacchio, Nathanael Gray

Research output: Contribution to journalArticlepeer-review


The members of the Aurora kinase family play critical roles in the regulation of the cell cycle and mitotic spindle assembly and have been intensively investigated as potential targets for a new class of anticancer drugs. We describe a new highly potent and selective class of Aurora kinase inhibitors discovered using a phenotypic cellular screen. Optimized inhibitors display many of the hallmarks of Aurora inhibition including endoreduplication, polyploidy, and loss of cell viability in cancer cells. Structure - activity relationships with respect to kinome-wide selectivity and guided by an Aurora B co-crystal structure resulted in the identification of key selectivity determinants and discovery of a subseries with selectivity toward Aurora A. A direct comparison of biochemical and cellular profiles with respect to published Aurora inhibitors including VX-680, AZD1152, MLN8054, and a pyrimidine-based compound from Genentech demonstrates that compounds 1 and 3 will become valuable additional pharmacological probes of Aurora-dependent functions.

Original languageEnglish
Pages (from-to)185-196
Number of pages12
JournalACS Chemical Biology
Issue number1
Publication statusPublished - Jan 20 2012

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine


Dive into the research topics of 'Selective aurora kinase inhibitors identified using a taxol-induced checkpoint sensitivity screen'. Together they form a unique fingerprint.

Cite this